07:41 AM EDT, 06/17/2024 (MT Newswires) -- Novo Nordisk ( NVO ) Chief Executive Lars Jorgensen has agreed to testify voluntarily before the Senate Committee on Health, Education, Labor, and Pensions about the high prices of Ozempic and Wegovy in the US, Sen. Bernie Sanders said Friday.

Sanders, committee chair, said the scheduled subpoena vote will be cancelled and the hearing will be held in September.

The Senate panel is looking into why Americans are paying up to 15 times more for Ozempic and Wegovy than people in other countries, Sanders said.

Price: 141.80, Change: -0.70, Percent Change: -0.49